Healthcare Services

Malignant Pleural Effusion Market Growth Trends and Forecast Through 2030

April 23, 2026April 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Malignant Pleural Effusion Market Expected To Scale Between 2026 And 2030?

The malignant pleural effusion market size has experienced strong growth in recent years. It is projected to increase from $4.73 billion in 2025 to $5.05 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.8%. This historical growth can be attributed to factors such as the rising incidence of metastatic cancers, the limited curative treatment options available, the reliance on repeated thoracentesis for symptom management, the expansion of hospital-based cancer care, and the progressive adoption of pleurodesis techniques.

The malignant pleural effusion market is projected to experience robust expansion over the coming years. By 2030, its valuation is anticipated to reach $6.52 billion, exhibiting a compound annual growth rate (CAGR) of 6.6%. This projected growth during the forecast period is driven by several factors, including the increasing global incidence of cancer, continuous improvements in pleural catheter technologies, a greater focus on outpatient and home-based care models, enhanced precision in diagnostic imaging, and an escalating need for treatments prioritizing patient quality of life. Key developments expected within this period involve the rising adoption of indwelling pleural catheters for sustained management, a growing inclination towards minimally invasive pleural procedures, the broader incorporation of systemic cancer therapies into MPE management strategies, an increased emphasis on symptom alleviation and palliative care methods, and the wider application of imaging-guided diagnostic and treatment interventions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22047&type=smp

Which Strong Drivers Are Impacting The Malignant Pleural Effusion Market Growth?

An anticipated increase in lung cancer cases is poised to drive the growth of the Malignant Pleural Effusion Market in the foreseeable future. Lung cancer is a condition marked by the uncontrolled multiplication of abnormal cells within the lungs, which can develop into tumors and disrupt normal lung function. This rise in lung cancer cases is primarily linked to smoking and tobacco use, as prolonged exposure to harmful chemicals in cigarettes damages lung tissues, triggers genetic mutations, and fosters the unrestrained proliferation of cancerous cells, substantially increasing the risk of developing the disease. Malignant pleural effusion signifies advanced lung cancer progression by facilitating the spread of tumors within the pleural cavity, leading to impaired respiratory function and a less favorable prognosis. For instance, in January 2023, data from the American Cancer Society Facts and Figures, a US-based professional organizations company, estimated new lung and bronchus cancer cases at 236,740 in 2022 and 238,340 in 2023. During the same period, estimated deaths were 130,180 in 2022 and 127,070 in 2023. Consequently, the increasing incidence of lung cancer is a significant factor propelling the expansion of the Malignant Pleural Effusion Market. The enhancement of healthcare infrastructure is anticipated to drive the expansion of the Malignant Pleural Effusion Market in the future. Healthcare infrastructure refers to the foundational physical, technological, and organizational elements required for delivering medical services, including hospitals, clinics, specialized equipment, IT systems, and personnel. Improvements in this infrastructure are driven by the need for more effective disease management, contributing to greater healthcare accessibility, efficiency, and quality of care. Such advancements facilitate the diagnosis, treatment, and management of malignant pleural effusion by offering access to cutting-edge medical technologies, well-equipped facilities, and expert care, ultimately leading to improved patient outcomes. For instance, in May 2023, the American Health Care Association, a US-based nonprofit organization, noted a 0.591% increase in the number of hospitals in the United States from the preceding year, rising from 6,093 to 6,129. Therefore, the betterment of healthcare infrastructure is a key factor stimulating the growth of the Malignant Pleural Effusion Market.

How Is Segmentation Applied In The Malignant Pleural Effusion Market Segment Analysis?

The malignant pleural effusion market covered in this report is segmented –

1) By Treatment: Systemic Therapy, Therapeutic Thoracentesis, Thoracic Drainage And Pleurodesis, Indwelling Pleural Catheter

2) By Diagnosis: Pleural Fluid Cytology, Immunohistochemical Tests, Imaging Tests, Pleural Thoracentosis, Pleuroscopy, Pleural Biopsy

3) By End Users: Hospitals, Ambulatory Clinics, Other End Users

Subsegments:

1) By Systemic Therapy: Chemotherapy, Targeted Therapy, Immunotherapy

2) By Therapeutic Thoracentesis: Single-Time Thoracentesis, Repeated Thoracentesis

3) By Thoracic Drainage And Pleurodesis: Chemical Pleurodesis, Mechanical Pleurodesis

4) By Indwelling Pleural Catheter: Tunneled Pleural Catheter, Non-Tunneled Pleural Catheter

Which Trends Are Contributing To Changes In The Malignant Pleural Effusion Market?

Leading companies in the malignant pleural effusion market are concentrating on developing advanced products, such as fully-implantable automatic fluid-shunt devices, to enhance patient comfort and decrease hospital visits. A fully-implantable automatic fluid-shunt device is a medical apparatus placed within the body that autonomously drains excess pleural fluid from the lungs into the abdomen or another region, thereby helping to relieve breathlessness, reduce the necessity for repeated hospital procedures, and improve the patient’s quality of life. For example, in October 2023, Pleural Dynamics, a US-based medical device company, introduced the ACES Automatic Continuous Effusion Shunt System. This device consists of a resilient, flexible pump chamber implanted beneath the skin between the ribs, with one catheter situated in the pleural space and another in the peritoneal space. As the patient inhales and exhales, the internal pump extension compresses and decompresses between adjacent ribs, propelling fluid from the pleural cavity to the abdomen where it is reabsorbed; additionally, the system permits manual activation via an external compression extension. Significant characteristics of this system include its entirely implantable design, absence of external drainage tubing or suction bottles, a pumping function that automatically activates with breathing, a short hospital stay for its placement, and continuous symptom relief for recurring effusions.

Who Are The Companies Participating In The Malignant Pleural Effusion Market Environment?

Major companies operating in the malignant pleural effusion market are Becton Dickinson and Company, Cook Medical LLC, Merit Medical Systems Inc, Argon Medical Devices Inc, B Braun SE, Medtronic plc, Smiths Medical, Teleflex Incorporated, Cardinal Health Inc, Getinge AB, AngioDynamics Inc, Rocket Medical plc, Redax SpA, Atrium Medical Corporation, PolyMedicure Ltd, Troge Medical GmbH, Vygon SA, ICU Medical Inc, ConvaTec Group plc, Baxter International Inc

Get The Full Malignant Pleural Effusion Market Report:

https://www.thebusinessresearchcompany.com/report/malignant-pleural-effusion-global-market-report

Which Region Has The Greatest Market Share In The Malignant Pleural Effusion Market?

North America was the largest region in the malignant pleural effusion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malignant pleural effusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Malignant Pleural Effusion Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/malignant-pleural-effusion-global-market-report

Browse Through More Reports Similar to the Global Malignant Pleural Effusion Market 2026, By The Business Research Company

Acoustic Neuroma Market Report 2026

https://www.thebusinessresearchcompany.com/report/acoustic-neuroma-global-market-report

Paraganglioma Market Report

https://www.thebusinessresearchcompany.com/report/paraganglioma-global-market-report

Adult Malignant Glioma Therapeutics Market Report

https://www.thebusinessresearchcompany.com/report/adult-malignant-glioma-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795